Each dose (0.2 ml for subcutaneous or 0.05 ml for in ovo) of the vaccine suspension contains:
Active substances:
Cell-associated, live recombinant Marek’s disease (MD) virus, serotype 1, strain RN1250: 2.9 to 3.9 log10 PFU*
Cell-associated, live recombinant turkey herpesvirus (HVT), strain vHVT013-69, expressing the VP2 protein gene of infectious bursal disease (IBD) virus: 3.6 to 4.4 log10 PFU*
*PFU: plaque forming units.
Excipients:
For the full list of excipients, see "Pharmaceutical particulars" section.